How does this protocol work?

The Blood Sugar Support & Craving Reduction Protocol Package utilizes the peptide Semaglutide.

When the peptide Semaglutide is injected, it acts as an agonist to GLP-1 receptors in the body, which helps to stimulate insulin production, reduce glucagon secretion, and delay gastric emptying. This can help to reduce blood glucose levels and further improve glycemic control.

As a result, users can experience reduced appetite which often leads to weight loss. Other known benefits are improved heart, liver, and lung function and the slowing/prevention of Alzheimer's disease. Improved mood, better sleep quality, and reduced fatigue have also been reported.

Semaglutide should not be used as a quick fix or "miracle" weight loss regimen. However, it can be a helpful aid to establishing healthy eating habits.

Semaglutide is an effective agent for glycemic control and is especially beneficial for those with type 2 diabetes. Treatment with Semaglutide has been shown to reduce A1C levels, fasting glucose levels, and the risk of cardiovascular events in patients with type 2 diabetes (likely due to the fact that Semaglutide helps to reduce blood pressure and LDL cholesterol).*

* Please note that every individual needs a different dosage of Semaglutide, depending on their body's need and size, and like all peptides, every individual's results may vary. Semaglutide may cause mild nausea, diarrhea, constipation, and mild headaches in some cases. If any of these side effects occur, users should decrease their dosage.

What does this protocol help with?

The Blood Sugar Support & Craving Reduction Protocol Package has been shown to aid in the following conditions:

• Type 2 Diabetes
• Slowing/Prevention of Alzheimer's & Parkinson's
• Obesity
• Cardiovascular Risk
• Non-Alcoholic Fatty Liver Disease
• Chronic Kidney Disease
• Metabolic Syndrome
• Reduce Unhealthy Cravings

New research is continuously being performed resulting in new exciting benefits of these peptides.

To see if you are a possible candidate for this protocol, contact us at 208-430-0540.